166 related articles for article (PubMed ID: 27690293)
1. Socioeconomic evaluation of vagus stimulation: A controlled national study.
Jennum P; Sabers A; Christensen J; Ibsen R; Kjellberg J
Seizure; 2016 Nov; 42():15-19. PubMed ID: 27690293
[TBL] [Abstract][Full Text] [Related]
2. Impact of vagus nerve stimulation on secondary care burden in children and adults with epilepsy: Review of routinely collected hospital data in England.
Camp C; Smithson WH; Bunker M; Burke T; Hughes D
Epilepsy Behav; 2015 Nov; 52(Pt A):68-73. PubMed ID: 26409132
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080
[TBL] [Abstract][Full Text] [Related]
4. Vagus nerve stimulation therapy in a developing country: a long term follow up study and cost utility analysis.
Aburahma SK; Alzoubi FQ; Hammouri HM; Masri A
Seizure; 2015 Feb; 25():167-72. PubMed ID: 25468513
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy.
Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
Epilepsy Behav; 2011 Oct; 22(2):370-5. PubMed ID: 21872534
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic outcome of epilepsy surgery: A controlled national study.
Jennum P; Sabers A; Christensen J; Ibsen R; Kjellberg J
Seizure; 2016 Nov; 42():52-56. PubMed ID: 27770730
[TBL] [Abstract][Full Text] [Related]
7. Long-term socioeconomic consequences and health care costs of childhood and adolescent-onset epilepsy.
Jennum P; Christensen J; Ibsen R; Kjellberg J
Epilepsia; 2016 Jul; 57(7):1078-85. PubMed ID: 27321903
[TBL] [Abstract][Full Text] [Related]
8. Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
Purser MF; Mladsi DM; Beckman A; Barion F; Forsey J
Adv Ther; 2018 Oct; 35(10):1686-1696. PubMed ID: 30143957
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy.
de Kinderen RJ; Postulart D; Aldenkamp AP; Evers SM; Lambrechts DA; Louw AJ; Majoie MH; Grutters JP
Epilepsy Res; 2015 Feb; 110():119-31. PubMed ID: 25616464
[TBL] [Abstract][Full Text] [Related]
10. The vagal nerve stimulation outcome, and laryngeal effect: Otolaryngologists roles and perspective.
Al Omari AI; Alzoubi FQ; Alsalem MM; Aburahma SK; Mardini DT; Castellanos PF
Am J Otolaryngol; 2017; 38(4):408-413. PubMed ID: 28390806
[TBL] [Abstract][Full Text] [Related]
11. Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.
Chambers A; Bowen JM
Ont Health Technol Assess Ser; 2013; 13(18):1-37. PubMed ID: 24228081
[TBL] [Abstract][Full Text] [Related]
12. Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery.
Elliott RE; Carlson C; Kalhorn SP; Moshel YA; Weiner HL; Devinsky O; Doyle WK
Epilepsy Behav; 2009 Nov; 16(3):454-60. PubMed ID: 19767244
[TBL] [Abstract][Full Text] [Related]
13. Vagus nerve stimulation for children with treatment-resistant epilepsy: a consecutive series of 141 cases.
Elliott RE; Rodgers SD; Bassani L; Morsi A; Geller EB; Carlson C; Devinsky O; Doyle WK
J Neurosurg Pediatr; 2011 May; 7(5):491-500. PubMed ID: 21529189
[TBL] [Abstract][Full Text] [Related]
14. Outcome of vagus nerve stimulation for drug-resistant epilepsy: the first three years of a prospective Japanese registry.
Kawai K; Tanaka T; Baba H; Bunker M; Ikeda A; Inoue Y; Kameyama S; Kaneko S; Kato A; Nozawa T; Maruoka E; Osawa M; Otsuki T; Tsuji S; Watanabe E; Yamamoto T
Epileptic Disord; 2017 Sep; 19(3):327-338. PubMed ID: 28832004
[TBL] [Abstract][Full Text] [Related]
15. Vagus nerve stimulation therapy in patients with autism spectrum disorder and intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry.
Levy ML; Levy KM; Hoff D; Amar AP; Park MS; Conklin JM; Baird L; Apuzzo ML
J Neurosurg Pediatr; 2010 Jun; 5(6):595-602. PubMed ID: 20515333
[TBL] [Abstract][Full Text] [Related]
16. Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After Implantation.
Evans K; Stamas N; Li Q; Vincent T; Halchenko Y; Zhang L; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
Clin Ther; 2023 Feb; 45(2):136-150. PubMed ID: 36746736
[TBL] [Abstract][Full Text] [Related]
17. Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation
Vincent T; Li Q; Zhang L; Stokes M; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
J Med Econ; 2022; 25(1):1218-1230. PubMed ID: 36384429
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous auricular vagus nerve stimulation for pediatric epilepsy: study protocol for a randomized controlled trial.
He W; Wang XY; Zhou L; Li ZM; Jing XH; Lv ZL; Zhao YF; Shi H; Hu L; Su YS; Zhu B
Trials; 2015 Aug; 16():371. PubMed ID: 26292720
[TBL] [Abstract][Full Text] [Related]
19. Economic and clinical evaluation of vagus nerve stimulation therapy.
Kopciuch D; Barciszewska AM; Fliciński J; Paczkowska A; Winczewska-Wiktor A; Jankowski R; Steinborn B; Nowakowska E
Acta Neurol Scand; 2019 Oct; 140(4):244-251. PubMed ID: 31165476
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive long-term outcome of best drug treatment with or without add-on vagus nerve stimulation for epilepsy: a retrospective matched pairs case-control study.
Hoppe C; Wagner L; Hoffmann JM; von Lehe M; Elger CE
Seizure; 2013 Mar; 22(2):109-15. PubMed ID: 23206433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
